V

Vimta Labs

(NSE: VIMTALABS)

VIMTALABS

338.35

0.00 (0.00%)

Vimta Labs Price Chart

Note: The data used to display charts is delayed by 15 mins as per guidelines.

Vimta Labs Price Chart

Note: The data used to display charts is delayed by 15 mins as per guidelines.

Vimta Labs Price Summary

Today High

340

Today Low

327.65

52 Week High

340

52 Week Low

327.65

Vimta Labs Fundamentals

Market Cap

807.4 Cr

CASA

0.0

No. Of Shares

2.2 Cr

P/E

16.7

P/B

1.8

Face Value

2.0

Dividend Yeild

1.2

Book Value

87.9

Net Interest Income

4.2

Cost to Income

NA

Promoter Holdings

37.5

EPS

9.6

CAR

NA

ROE

11.6

ROCE

14.2

Profit Growth

NA

Vimta Labs Peer Comparison

COMPANY

PRICE

MCAP (cr)

P/B

P/E

EPS

ROE

ROCE

NII

Future Entr - DVR

7.55

NA

NA

NA

NA

NA

NA

NA

Jain Irrigation - DVR

20.1

NA

NA

NA

NA

NA

NA

NA

Vimta Labs

338.35

807.4 Cr

1.8

16.7

9.6

11.6

14.2

4.2

Sanghvi Movers

225.05

774.6 Cr

0.6

0.0

-5.2

-3.1

-0.6

81.8

Antony Waste

301.5

868.4 Cr

4.1

49.6

4.9

11.2

12.1

125.2

Universus Photo

534.7

571.8 Cr

1.1

12.1

13.0

9.2

12.2

16.7

FAQ’s on Vimta Labs

About Vimta Labs

Vimta Labs is India’s leading contract research and testing organization. Established in 1984, Vimta has an envious track record of serving several market leaders across the globe.

Vimta supports regulatory authorities in mandatory certification of food and agri products exported from India. Vimta assists the food industry commissions for nutritional labelling, food safety evaluations, trace analysis and shelf life studies.

Vimta has a team of 684 professionals comprising 446 scientists in various disciplines such as chemistry, pharma, medicine, microbiology, molecular biology and informatics. The team is slated to double in next three years.

Vimta is a multi-site organization with more than 300,000 sqft world class laboratory facilities. The technologies deployed at Vimta are current and leading edge, duly validated.

Vimta has over 12 years of experience in providing preclinical services to Pharma companies world-wide accordance with the guidelines prescribed by international agencies.

Vimta has a state-of-art building of Class 10,000 Pre-clinical facility with a total built up area of 33,000 sq.ft. with 32 rodent experimental rooms, 5 procedure rooms, separate quarantine facility and distinct non-rodent facility with 48 SS kennels with a comfortable perch, liberal exercise area.

It provides services in pharmacology, toxicology and DMPK areas. The toxicology services include but not limited to in-vivo and in-vitro genotoxicity, acute to chronic toxicity, carcinogenicity, reproductive toxicity studies, safety pharmacology, and immunotoxicology. Pharmacology services are available in various therapeutics areas such as pain & inflammation, metabolic disorders, respiratory, CNS, and xenograft & allograft models for oncology. In addition to the regulatory studies we use tailor-made in vitro and in vivo ADME techniques to help profile your drug candidate in both rodent and non-rodent animals models.

Services offered by the company:

  • Advanced Molecular Biology
  • Food and Agriculture
  • Drugs & Pharma
  • Water
  • Environmental Assessments
  • Clinical Research
  • Clinical Reference Lab Services
  • Preclinical Research
  • Genomics Online Ordering

 Achievements/ recognition

  •    NABL as per ISO 15189:2007

Trade Vimta Labs today

Create a free portfolio in Trinkerr and earn and grow along with peers